Oncogenic activation of the mTOR signal pathway is involved in promoting immune escape by driving the expression of PD-L1, subsequently decreasing the concentration of tumor-infiltrating T cells 49, 50 (Figure 1C). The gene discussed is MTOR; the disease is neoplasm.